2016’s lifesaving research

Last year was game-changing thanks to passionate donors like you.

Research funded by the Canadian Cancer Society is making a real difference. Our recently released Top 10 Research Stories of 2016 highlight some of last year’s major research successes, including the following three projects, which have the potential to save lives and change the face of cancer forever.

Changing genetics in childhood brain cancer

Medulloblastoma is the most common brain cancer in children. If this cancer comes back after treatment, it becomes increasingly difficult to treat. Dr Michael Taylor from SickKids Hospital, and an international team, discovered that the genetics of medulloblastoma changes dramatically when it returns, which will help find more effective treatments.


A promising new strategy to block breast cancer

Ranitidine (Zantac) is commonly used for heartburn relief. Dr Jean Marshall from Dalhousie University has discovered that it can also block breast cancer in mice. If it also works in people, it could be quickly repurposed as a safe and affordable breast cancer treatment and prevention tool for some women.

A gel to improve immunotherapy

Cancer immunotherapy teaches immune cells to attack tumours, but it only works if enough immune cells are delivered to the cancer site. Dr Réjean Lapointe and his Team from Centre de recherche du CHUM – Pavillon Notre-Dame, developed a gel to target and release cancer-fighting immune cells at just the right spot. Further developments could greatly improve treatment for cancer patients.

The Society’s highly competitive, gold standard expert-review selection process allows us to fund excellence, and last year’s achievements in research have demonstrated what we can achieve when our donors help us make dedicated investments in research. Please click here to read more about the Top 10 Research Stories of 2016.